Diker Management’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-4,486
| Closed | -$207K | – | 33 |
|
|
2021
Q4 | $207K | Buy |
+4,486
| New | +$207K | 0.14% | 36 |
|
|
2020
Q2 | – | Sell |
-7,411
| Closed | -$302K | – | 38 |
|
|
2020
Q1 | $302K | Sell |
7,411
-1,190
| -14% | -$48.5K | 0.13% | 29 |
|
|
2019
Q4 | $530K | Buy |
8,601
+210
| +3% | +$12.9K | 0.34% | 21 |
|
|
2019
Q3 | $612K | Hold |
8,391
| – | – | 0.4% | 20 |
|
|
2019
Q2 | $690K | Hold |
8,391
| – | – | 0.29% | 21 |
|
|
2019
Q1 | $592K | Hold |
8,391
| – | – | 0.36% | 24 |
|
|
2018
Q4 | $378K | Buy |
8,391
+1,410
| +20% | +$63.5K | 0.16% | 43 |
|
|
2018
Q3 | $395K | Hold |
6,981
| – | – | 0.14% | 40 |
|
|
2018
Q2 | $466K | Hold |
6,981
| – | – | 0.17% | 41 |
|
|
2018
Q1 | $406K | Sell |
6,981
-214
| -3% | -$12.4K | 0.14% | 47 |
|
|
2017
Q4 | $464K | Buy |
7,195
+145
| +2% | +$9.35K | 0.17% | 50 |
|
|
2017
Q3 | $370K | Hold |
7,050
| – | – | 0.15% | 47 |
|
|
2017
Q2 | $330K | Hold |
7,050
| – | – | 0.15% | 49 |
|
|
2017
Q1 | $349K | Sell |
7,050
-1,040
| -13% | -$51.5K | 0.16% | 47 |
|
|
2016
Q4 | $490K | Sell |
8,090
-1,720
| -18% | -$104K | 0.21% | 42 |
|
|
2016
Q3 | $651K | Sell |
9,810
-1,090
| -10% | -$72.3K | 0.23% | 37 |
|
|
2016
Q2 | $608K | Hold |
10,900
| – | – | 0.24% | 36 |
|
|
2016
Q1 | $367K | Buy |
10,900
+2,300
| +27% | +$77.4K | 0.14% | 38 |
|
|
2015
Q4 | $388K | Hold |
8,600
| – | – | 0.11% | 64 |
|
|
2015
Q3 | $340K | Buy |
+8,600
| New | +$340K | 0.08% | 82 |
|